EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence

Lijuan Gao, Yongsheng Qin, Yudai Xu, Ju Su, Zhicheng Cai, Zhongyu Hu, Ruohu Shi, Xinyi Mu, Shiying Cen, Chanchan Xiao, Guobing Chen

Frontiers in Aging · 30.07.2026 · 7

DOI: 10.3389/fragi.2026.1868486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Aging, online erschienen am 30.07.2026. Verfasst von Lijuan Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intensifying global population aging has rendered the development of anti-aging drugs a core challenge in the life sciences domain. Traditional models struggle to address the systemic and networked nature of aging. Multi-omics technologies provide a panoramic perspective for deciphering molecular networks of aging, while Artificial Intelligence (AI) has demonstrated significant advantages in target discovery, drug screening, and clinical trial optimization. This review systematically elaborates on the pathological characteristics and molecular mechanisms of aging, analyzes the application paradigms of multi-omics in biomarker screening, mechanism elucidation, and high-throughput screening, and discusses the core value and technical bottlenecks of AI in target prediction, virtual screening, and trial design. Simultaneously, this paper addresses critical challenges including ethical controversies and data standardization currently confronting the field, and explores the prospects of precision anti-aging drug development and personalized treatment strategies driven by deep integration of multi-omics and AI. This approach offers novel theoretical frameworks and practical pathways for extending human healthspan.

Schlagwörter

Stichwörter der Autor:innen

Anti-aging drugsartificial intelligenceclinical translationdrug screeningmulti-omics

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Institute of Geriatric Immunology, School of Medicine, Jinan University, Guangzhou, China.
  • School of Environmental Engineering, Guangdong Polytechnic of Environment Protection Engineering, Foshan, Guangdong, China.
  • The Sixth Affiliated Hospital of Jinan University (Dongguan Eastern Central Hospital), Jinan University, Dongguan, Guangdong, China.
  • First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China.
  • Office of Scientific Research and Development, Jinan University, Guangzhou, Guangdong, China.

Zitieren

APA

Gao, L., Qin, Y., Xu, Y., Su, J., Cai, Z., Hu, Z., Shi, R., Mu, X., Cen, S., Xiao, C., & Chen, G. (2026). Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence. Frontiers in Aging, 7. https://doi.org/10.3389/fragi.2026.1868486

Vancouver

Gao L, Qin Y, Xu Y, Su J, Cai Z, Hu Z, et al. Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence. Frontiers in Aging. 2026;7. doi:10.3389/fragi.2026.1868486

BibTeX
@article{Gao2026,
  author = {Gao, Lijuan and Qin, Yongsheng and Xu, Yudai and Su, Ju and Cai, Zhicheng and Hu, Zhongyu and Shi, Ruohu and Mu, Xinyi and Cen, Shiying and Xiao, Chanchan and Chen, Guobing},
  title = {Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence},
  journal = {Frontiers in Aging},
  year = {2026},
  volume = {7},
  doi = {10.3389/fragi.2026.1868486}
}
Kostenlos starten →